# Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension

> **NCT05951166** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Gradient Denervation Technologies** · enrollment: 5 (actual)

## Conditions studied

- Heart Failure Patients With Pulmonary Hypertension

## Interventions

- **DEVICE:** Gradient Denervation System

## Key facts

- **NCT ID:** NCT05951166
- **Lead sponsor:** Gradient Denervation Technologies
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-05-05
- **Primary completion:** 2024-07-31
- **Final completion:** 2025-07-01
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2025-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05951166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05951166, "Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05951166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*